Alfresa Fine Chemical

Alfresa Fine Chemical is a Japanese pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and diagnostic reagents. As a core subsidiary of Alfresa Holdings Corporation, the company operates as a Contract Development and Manufacturing Organization (CDMO), offering services from process development to commercial-scale production. Their technical expertise includes high-potency API (HPAPI) manufacturing and complex small molecule synthesis. The company maintains multiple GMP-compliant facilities in Japan, supporting a wide range of therapeutic areas including cardiovascular and central nervous system disorders. Alfresa Fine Chemical serves both domestic and international markets, providing critical chemical components for the global healthcare industry.